Elevated ROS levels and DNA fragmentation in cancer cells are also associated with apoptosis and autophagy, indicating that this drug combination can induce apoptosis- or autophagy-mediated cell death in KRAS-mutated PDAC. This evidence concerns the gene KRAS and cancer.